MVM Partners

Latest statistics and disclosures from MVM Partners's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are FNA, MDXH, Optinose, and represent 100.00% of MVM Partners's stock portfolio.
  • Added to shares of these 1 stock: Optinose (+$6.4M).
  • Started 1 new stock position in Optinose.
  • Reduced shares in these 2 stocks: OPTN (-$9.5M), FNA (-$5.2M).
  • Sold out of its position in OPTN.
  • MVM Partners was a net seller of stock by $-8.3M.
  • MVM Partners has $124M in assets under management (AUM), dropping by 35.72%.
  • Central Index Key (CIK): 0001947083

Tip: Access up to 7 years of quarterly data

Positions held by MVM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for MVM Partners

MVM Partners holds 3 positions in its portfolio as reported in the December 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Paragon 28 (FNA) 86.0 $107M -4% 10M 10.30
 View chart
MDXHealth SA Shs New (MDXH) 8.9 $11M 4.7M 2.35
 View chart
Optinose Com New 5.1 $6.4M NEW 974k 6.54
 View chart

Past Filings by MVM Partners

SEC 13F filings are viewable for MVM Partners going back to 2022